NEW YORK, Nov. 6 – Pyrosequencing and Genomics Collaborative said Tuesday that they had agreed to jointly collaborate to generate genomic information that could be used to develop diagnostics and therapeutic products for cardiovascular disease.

The deal is Pyrosequencing’s second such deal in the diagnostics market in as many days. On Monday, the Uppsala, Sweden-based company announced that it would work with the Cleveland Clinic to co-develop rapid identification and diagnostic tests for mycobacteria.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.